Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB-Reference-Cited by-同舟云学术

Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB

Published:2013-07-05 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sharma Surendra K¹,Sharma Anju²,Kadhiravan Tamilarasu³,Tharyan Prathap⁴

Affiliation:

1. All India Institute of Medical Sciences; Department of Medicine; Room 3097, Teaching Block Ansari Nagar New Delhi India 110029

2. Indian Council of Medical Research; Division of Publication & Information; V. Ramalingaswami Bhawan Post Box 4911 New Delhi India 110029

3. Jawaharlal Institute of Postgraduate Medical Education and Research; Department of Medicine; Dhanvantri Nagar Puducherry India 605006

4. Christian Medical College; South Asian Cochrane Network & Centre, Prof. BV Moses & ICMR Advanced Centre for Research & Training in Evidence Informed Health Care; Carman Block II Floor CMC Campus, Bagayam Vellore Tamil Nadu India 632002

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD007545.pub2/fullpdf

Reference159 articles.

1. Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial;Chan;International Journal of Tuberculosis and Lung Diseases,2012

2. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong;Hong Kong Chest Service/Tuberculosis Research Centre;The American Review of Respiratory Disease,1992

3. Initial experience on rifampin and pyrazinamide versus isoniazid in the treatment of latent tuberculosis infection among patients with silicosis in Hong Kong;Leung;Chest,2003

4. [Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood--a pilot project];Magdorf;Pneumologie (Stuttgart, Germany),1994

5. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis];Martinez Alfaro;Medicina clinica,1998

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis;Expert Opinion on Drug Safety;2024-09-04

2. Comorbidities and Contraindicated Medications in Patients with Chronic Hepatitis C Infection in Japan: a Real-World Database Study;Kanzo;2024-08-01

3. The incorporation of the 3HP regimen for tuberculosis preventive treatment in the Brazilian health system: a secondary-database nationwide analysis;Frontiers in Medicine;2024-01-05

4. Preventive treatment for latent tuberculosis from Indian perspective;Lung India;2024

5. Uptake and Completion of Tuberculosis Preventive Treatment Using 12-Dose, Weekly Isoniazid–Rifapentine Regimen in Bangladesh: A Community-Based Implementation Study;Tropical Medicine and Infectious Disease;2023-12-20